APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology Generic Injectable Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oncology Generic Injectable Drugs Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry ResearchOncology Generic Injectable Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Generic Injectable Drugs Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Oncology Generic Injectable Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Generic Injectable Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Generic Injectable Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oncology Generic Injectable Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oncology Generic Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oncology Generic Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology Generic Injectable Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology Generic Injectable Drugs include Teva Pharmaceutical, Novartis, Mylan, Roche, Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca and Natco Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oncology Generic Injectable Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncology Generic Injectable Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology Generic Injectable Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology Generic Injectable Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oncology Generic Injectable Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncology Generic Injectable Drugs Market by Company

Teva Pharmaceutical

Novartis

Mylan

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

AstraZeneca

Natco Pharma

Oncology Generic Injectable Drugs Segment by Type

Large Molecule Drugs

Small Molecule Drugs

Oncology Generic Injectable Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Oncology Generic Injectable Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Generic Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Generic Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Generic Injectable Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology Generic Injectable Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oncology Generic Injectable Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Large Molecule Drugs Table 2. Major Company of Small Molecule Drugs Table 3. Global Oncology Generic Injectable Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Oncology Generic Injectable Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oncology Generic Injectable Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Oncology Generic Injectable Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Oncology Generic Injectable Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Oncology Generic Injectable Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oncology Generic Injectable Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oncology Generic Injectable Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Oncology Generic Injectable Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Oncology Generic Injectable Drugs Industry Trends Table 25. Oncology Generic Injectable Drugs Industry Drivers Table 26. Oncology Generic Injectable Drugs Industry Opportunities and Challenges Table 27. Oncology Generic Injectable Drugs Industry Restraints Table 28. Global Oncology Generic Injectable Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oncology Generic Injectable Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Oncology Generic Injectable Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Oncology Generic Injectable Drugs Sales Share by Company (2021-2026) Table 32. Global Oncology Generic Injectable Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Oncology Generic Injectable Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oncology Generic Injectable Drugs Major Company Production Sites and Headquarters Table 35. Global Oncology Generic Injectable Drugs Company, Product Type & Application Table 36. Global Oncology Generic Injectable Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oncology Generic Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oncology Generic Injectable Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oncology Generic Injectable Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Oncology Generic Injectable Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oncology Generic Injectable Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oncology Generic Injectable Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Oncology Generic Injectable Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Oncology Generic Injectable Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Oncology Generic Injectable Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oncology Generic Injectable Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oncology Generic Injectable Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Oncology Generic Injectable Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Oncology Generic Injectable Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Oncology Generic Injectable Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oncology Generic Injectable Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Oncology Generic Injectable Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Oncology Generic Injectable Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Oncology Generic Injectable Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oncology Generic Injectable Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oncology Generic Injectable Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Oncology Generic Injectable Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Company Information Table 72. Teva Pharmaceutical Business Overview Table 73. Teva Pharmaceutical Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Oncology Generic Injectable Drugs Product Portfolio Table 75. Teva Pharmaceutical Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Oncology Generic Injectable Drugs Product Portfolio Table 80. Novartis Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Mylan Oncology Generic Injectable Drugs Product Portfolio Table 85. Mylan Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Roche Oncology Generic Injectable Drugs Product Portfolio Table 90. Roche Recent Development Table 91. Eli Lilly Company Information Table 92. Eli Lilly Business Overview Table 93. Eli Lilly Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Eli Lilly Oncology Generic Injectable Drugs Product Portfolio Table 95. Eli Lilly Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Pfizer Oncology Generic Injectable Drugs Product Portfolio Table 100. Pfizer Recent Development Table 101. GlaxoSmithKline Company Information Table 102. GlaxoSmithKline Business Overview Table 103. GlaxoSmithKline Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. GlaxoSmithKline Oncology Generic Injectable Drugs Product Portfolio Table 105. GlaxoSmithKline Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. AstraZeneca Oncology Generic Injectable Drugs Product Portfolio Table 110. AstraZeneca Recent Development Table 111. Natco Pharma Company Information Table 112. Natco Pharma Business Overview Table 113. Natco Pharma Oncology Generic Injectable Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Natco Pharma Oncology Generic Injectable Drugs Product Portfolio Table 115. Natco Pharma Recent Development Table 116. North America Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (k units) Table 118. North America Oncology Generic Injectable Drugs Sales Market Share by Country (2021-2026) Table 119. North America Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Oncology Generic Injectable Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Oncology Generic Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Oncology Generic Injectable Drugs Market Share by Country (2021-2026) Table 124. North America Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Oncology Generic Injectable Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (k units) Table 128. Europe Oncology Generic Injectable Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Oncology Generic Injectable Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Oncology Generic Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Oncology Generic Injectable Drugs Market Share by Country (2021-2026) Table 134. Europe Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Oncology Generic Injectable Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Oncology Generic Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Oncology Generic Injectable Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Oncology Generic Injectable Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (k units) Table 148. Latin America Oncology Generic Injectable Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Oncology Generic Injectable Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Oncology Generic Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Oncology Generic Injectable Drugs Market Share by Country (2021-2026) Table 154. Latin America Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Oncology Generic Injectable Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Oncology Generic Injectable Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Oncology Generic Injectable Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Oncology Generic Injectable Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Oncology Generic Injectable Drugs Distributors List Table 169. Oncology Generic Injectable Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Oncology Generic Injectable Drugs Image Figure 2. Global Oncology Generic Injectable Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology Generic Injectable Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology Generic Injectable Drugs Sales (2021-2032) & (k units) Figure 5. Large Molecule Drugs Image Figure 6. Global Large Molecule Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Small Molecule Drugs Image Figure 8. Global Small Molecule Drugs Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Oncology Generic Injectable Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oncology Generic Injectable Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Oncology Generic Injectable Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Oncology Generic Injectable Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Oncology Generic Injectable Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oncology Generic Injectable Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oncology Generic Injectable Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oncology Generic Injectable Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oncology Generic Injectable Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Online Pharmacies Image Figure 24. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Oncology Generic Injectable Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Oncology Generic Injectable Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Oncology Generic Injectable Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Oncology Generic Injectable Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Oncology Generic Injectable Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Oncology Generic Injectable Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Oncology Generic Injectable Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Oncology Generic Injectable Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Oncology Generic Injectable Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Oncology Generic Injectable Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Oncology Generic Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Oncology Generic Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oncology Generic Injectable Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Oncology Generic Injectable Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oncology Generic Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Oncology Generic Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oncology Generic Injectable Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Oncology Generic Injectable Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oncology Generic Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Oncology Generic Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oncology Generic Injectable Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Oncology Generic Injectable Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oncology Generic Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Oncology Generic Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oncology Generic Injectable Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Oncology Generic Injectable Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oncology Generic Injectable Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Oncology Generic Injectable Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Oncology Generic Injectable Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Oncology Generic Injectable Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Large Molecule Drugs
  • Small Molecule Drugs
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical
  • Novartis
  • Mylan
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Natco Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oncology Generic Injectable Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oncology Generic Injectable Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oncology Generic Injectable Drugs Market by Type
  6. 1.3.1 Large Molecule Drugs
  7. 1.3.2 Small Molecule Drugs
  8. 1.4 Global Oncology Generic Injectable Drugs Market Size by Type
  9. 1.4.1 Global Oncology Generic Injectable Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oncology Generic Injectable Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oncology Generic Injectable Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oncology Generic Injectable Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oncology Generic Injectable Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oncology Generic Injectable Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oncology Generic Injectable Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oncology Generic Injectable Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oncology Generic Injectable Drugs Industry Trends
  2. 2.2 Oncology Generic Injectable Drugs Industry Drivers
  3. 2.3 Oncology Generic Injectable Drugs Industry Opportunities and Challenges
  4. 2.4 Oncology Generic Injectable Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oncology Generic Injectable Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Oncology Generic Injectable Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Oncology Generic Injectable Drugs Price (2021-2026)
  4. 3.4 Global Oncology Generic Injectable Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology Generic Injectable Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Oncology Generic Injectable Drugs Company, Product Type & Application
  7. 3.7 Global Oncology Generic Injectable Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology Generic Injectable Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology Generic Injectable Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology Generic Injectable Drugs Tier 1, Tier 2, and Tier 3
4 Oncology Generic Injectable Drugs Regional Status and Outlook
  1. 4.1 Global Oncology Generic Injectable Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oncology Generic Injectable Drugs Historic Market Size by Region
  3. 4.2.1 Global Oncology Generic Injectable Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oncology Generic Injectable Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oncology Generic Injectable Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oncology Generic Injectable Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Oncology Generic Injectable Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oncology Generic Injectable Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oncology Generic Injectable Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oncology Generic Injectable Drugs by Application
  1. 5.1 Oncology Generic Injectable Drugs Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Oncology Generic Injectable Drugs Market Size by Application
  6. 5.2.1 Global Oncology Generic Injectable Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Oncology Generic Injectable Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Oncology Generic Injectable Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Oncology Generic Injectable Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Oncology Generic Injectable Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Oncology Generic Injectable Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Oncology Generic Injectable Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Oncology Generic Injectable Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Oncology Generic Injectable Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Oncology Generic Injectable Drugs Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Oncology Generic Injectable Drugs Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Oncology Generic Injectable Drugs Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Oncology Generic Injectable Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Oncology Generic Injectable Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Oncology Generic Injectable Drugs Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Natco Pharma
  50. 6.9.1 Natco Pharma Company Information
  51. 6.9.2 Natco Pharma Business Overview
  52. 6.9.3 Natco Pharma Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Natco Pharma Oncology Generic Injectable Drugs Product Portfolio
  54. 6.9.5 Natco Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Oncology Generic Injectable Drugs Sales by Country
  2. 7.1.1 North America Oncology Generic Injectable Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oncology Generic Injectable Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oncology Generic Injectable Drugs Market Size by Country
  6. 7.2.1 North America Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oncology Generic Injectable Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oncology Generic Injectable Drugs Sales by Country
  2. 8.1.1 Europe Oncology Generic Injectable Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oncology Generic Injectable Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oncology Generic Injectable Drugs Market Size by Country
  6. 8.2.1 Europe Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oncology Generic Injectable Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oncology Generic Injectable Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Oncology Generic Injectable Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oncology Generic Injectable Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oncology Generic Injectable Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oncology Generic Injectable Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oncology Generic Injectable Drugs Sales by Country
  2. 10.1.1 South America Oncology Generic Injectable Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oncology Generic Injectable Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oncology Generic Injectable Drugs Market Size by Country
  6. 10.2.1 South America Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oncology Generic Injectable Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oncology Generic Injectable Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Oncology Generic Injectable Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oncology Generic Injectable Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oncology Generic Injectable Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oncology Generic Injectable Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Oncology Generic Injectable Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oncology Generic Injectable Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oncology Generic Injectable Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oncology Generic Injectable Drugs Value Chain Analysis
  2. 12.1.1 Oncology Generic Injectable Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oncology Generic Injectable Drugs Production Mode & Process
  7. 12.2 Oncology Generic Injectable Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oncology Generic Injectable Drugs Distributors
  10. 12.2.3 Oncology Generic Injectable Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst